According to a new market research report "Neuroendoscopy Market by Product (Rigid (Videoscope, Fiberscope), Flexible endoscope), Usability (Reuse and Disposable), Application (Transnasal, Intraventricular, and Transcranial), Region (North America, Europe, Asia) - Global Forecast to 2022", published by MarketsandMarkets™, the global market is expected to reach USD 218.9 Million by 2022 from USD 170.5 Million in 2017, at a CAGR of 5.1%.
The growth of the Neuroendoscopy Market is attributed to favorable government initiatives, rising prevalence of neurological disorders, and benefits of neuroendoscopic surgery over conventional brain surgery.
Don’t miss out on business opportunities in Neuroendoscopy Market by Usability and Product.
Request PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=68126508
The high cost of neuroendoscopy procedures & equipment is the major restraint for the market.
The average list price of a neuroendoscopy system is as high as USD 10,000 to USD 15,000. Healthcare providers—particularly in developing countries such as India, Brazil, and Mexico—have low financial resources to invest in such costly sophisticated technologies. Moreover, healthcare staff needs to be trained for the efficient handling and maintenance of neuroendoscopy systems and equipment. This is a major issue as training costs for neuroendoscopic procedures are high. Considering the high cost of training, only a limited number of surgeons opt for undergoing training for neuroendoscopy (Source: Journal of Surgical Simulation). Owing to the high cost of equipment as well as the high training and maintenance costs, neuroendoscopy procedures are generally expensive. This is a major factor restraining the growth of the neuroendoscopy devices market.
Browse and in-depth TOC on "Neuroendoscopy Market"
75 - Tables
22 - Figures
101 - Pages
Transnasal Neuroendoscopy
Transnasal procedures help surgeons to approach the anterior cranial base, parasellar region, clivus, cavernous sinus, and craniovertebral junction in a less invasive manner as compared to conventional neurosurgery techniques. Transnasal neuroendoscopy is indicated for biopsies, removal of cysts, and removal of pituitary gland tumors and other obstructions. The advantages of transnasal neuroendoscopy include increased visualization with high light intensity in the deep-seated surgical field, clear display of patho-anatomical details, and extended viewing angle of neuroendoscopes (which enables surgeons to observe hidden parts of the surgical field).
Intraventricular Neuroendoscopy
Neuroendoscopic surgery for intraventricular brain tumors is one of the major applications of neuroendoscopy. This approach is used in selective conditions, such as tumor biopsy, concordant CSF diversion, treatment of non-communicating hydrocephalus, management of pineal tumor patients, fenestration of intracranial cysts, and removal of fibroid cysts. Factors such as the ease of use, increased visibility, and treatment of a large number of neurological conditions will drive the growth of this segment.
North America dominated the Neuroendoscopy Market in 2017
In 2017, North America dominated the market followed by Europe. The large share of this geographical segment is attributed to favorable reimbursement scenario in the US, rising incidence of cancer, increasing investments by hospitals to purchase new neuroendoscopic equipment, increasing research activities, and implementation of a new funding model for Canadian hospitals.
Request Sample Pages @ https://www.marketsandmarkets.com/requestsample.asp?id=68126508
The Neuroendoscopy Market includes various small and large players. Key players in this market are KARL STORZ(Germany), B.Braun Aesculap (Germany), Ackermann Instrumente (Germany), Adeor Medical (Germany), Hawk (China), Machida (Japan), Tonglu Wanhe Medical (China), Schindler (Germany), Clarus (US), LocaMed (UK), and Visionsense (US).
The global cerebral spinal fluid management market size is anticipated to reach USD 1.4 billion by 2022, according to a new report by Grand View Research, Inc.
Constant evaluation of various techniques by neurosurgeons for improvement of hydrocephalus management is expected to drive growth in this market.
Moreover, shunt manufacturers are engaged in the investment for development of novel and improved shunts in order to tackle the pitfalls associated with the existing designs.Significant increase in geriatric population across the globe as well as raise in incidence of chronic CNS associated disorders such as stroke can be attributed to projected growth.
Furthermore, grants for research in neuromodulation therapies in order to develop different products for prognosis of various nervous system associated disorders are expected to boost development.Further Key Findings from the Study Suggest:CSF management devices are expected to witness extensive competition owing to presence of several market players operating in this segment.
Rise in number of CSF associated disorders such as trauma and stroke are anticipated to boost demand for these products in the coming years.Cerebral spinal fluid management shunts captured the largest market share in terms of revenue generation in 2014.These devices are most commonly used for supplementing and replacing lost drainage capacity in case of CSF leak management.CSF drainage is anticipated to witness lucrative growth over the forecast period.This growth can be attributed to ongoing development for enhancing overall safety of guidance-based systems and anti-biotic impregnated catheters incorporation.In 2014, North America accounted for the largest share with respect to revenue generation.Factors contributive for the share include continuous increase in the number of Americans affected from Hydrocephalus coupled with ongoing research in neuroscience.Asia Pacific is expected to propel with fastest CAGR owing to constantly improving healthcare system in the region.Moreover, economic progress of Asia Pacific countries such as China has led to significant transformation of neurology and neurologic practices in the country.
This is one of the key drivers to propel progress in this region in the coming years.Some of the key players operating in the cerebrospinal fluid management market include Johnson & Johnson Services, Inc; B.Braun Melsungen AG; Magstim; Elekta AB; Medtronic, Inc.; Integra LifeSciences Corporation;Phoenix Biomedical Corp.; Sophysa; Spiegelberg GmbH & Co. KG; and Beckersmith Medical, Inc.These players are engaged in development of novel platforms for CSF management.Access full research report on global cerebral spinal fluid management market: www.grandviewresearch.com/industry-analysis/csf-management-market-analysis-market
Neurologist Best Doctor in Jaipurhttp://www.dramitbarala.com/#neurologist-best-doctor-in-jaipur-trained-doctorHere is a Neurologist Best Doctor in Jaipur who have a good reputation and excellence in the field of neurology.
The neurology doctor in jaipur has evolved as a centre of excellence in medicine providing highest quality standard of medical treatment to all sections of society.
We also have a team of trained resident doctors dedicated to the care of admitted neuro patients.
Interventional Neurology Market Research Report: By Disease Pathology (Cerebral Aneurysms, Ischemic Strokes, & Others), Product (Aneurysm Coiling & Embolization, Neurothrombectomy, Support Devices, & Others), End User – Global Forecast Till 2027 Interventional Neurology Market HighlightsThe global interventional neurology market is expected to expand at a strong 7.8% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR).
The report presents a complete picture of the global interventional neurology market to readers, including a detailed overview of the market’s historical growth trajectory and present condition in order to present forecasts for the market’s likely movement over the coming years.
Detailed forecasts regarding each segment of the interventional neurology market are provided in the report to enable informed decision making on the part of players operating in the market.
The use of minimally invasive, image-guided techniques in the interventional neurology field is a major factor acting on the global interventional neurology market.
The use of minimally invasive techniques is expected to grow in the coming years thanks to the growing awareness about their benefits over conventional techniques.
Environmental factors such as the increased stress associated with living in urban environments and the increasing prevalence of sedentary lifestyles are also likely to play a part in the increasing prevalence of neurological disorders in the coming years, leading to a growing demand from the interventional neurology market.Request Free Sample Copy at:https://www.marketresearchfuture.com/sample_request/7211Competitive Analysis:Leading players in the global interventional neurology market include Cook Medical, B. Braun Melsungen AG, W. L. Gore & Associates Inc., Merit Medical Systems Inc., Microport Scientific Corporation, Penumbra Inc., Terumo Corporation, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson, and Abbott Laboratories.Major players in the interventional neurology market are likely to focus on the development of more capable minimally invasive techniques in the coming years.
